Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase NA 2Phase 3 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 2Immunoglobulin Light-chain Amyloidosis 2Neoplasm, Residual 1

Interventions

Dexamethasone 4Whole-Body Irradiation 3Bortezomib 3pomalidomide 2fludarabine phosphate 2daratumumab 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Cyclosporine 2Cyclophosphamide 24-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2venetoclax 1darlin protein, Dictyostelium 1Thiotepa 1Oxycodone 1Music Therapy 1Moxifloxacin 1Morphine 1Methadone 1Melphalan 1Massage 1Hyaluronoglucosaminidase 1Focal Adhesion Protein-Tyrosine Kinases 1Fluorescent Antibody Technique 1Etoposide 1Doxycycline 1Ciprofloxacin 1Carmustine 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Immunoglobulin Light-chain Amyloidosis × daratumumab × Clear all
NCT06192979 2026-03-09

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

Peking University People's Hospital

Phase NA Recruiting
41 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT06455748 2024-06-12

Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study

First Affiliated Hospital of Wenzhou Medical University

Phase NA Recruiting
20 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡